Search results
Battling bureaucracy after burn pits: Why are contractors left behind?
Military Times via Yahoo News· 1 day agoIt was an unusual injury, doctors told him, so they ran some tests. Soon it made more sense. They...
'General Hospital's John J. York Talks Returning After Cancer Battle
Entertainment Tonight· 2 days agoGeneral Hospital star John J. York became emotional while discussing his battle with cancer and the...
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
MedPage Today· 5 days agoMedPage Today brought together three expert leaders in the field: Moderator...
Soap star opens up about fighting 2 types of cancer
Good Morning America via Yahoo News· 2 days agoHospital" star John York is opening up about his cancer treatment for the first time on "Good Morning America." York has been battling two forms of...
John J. York opens up about 'very welcoming' return to 'General Hospital' amid cancer battle
USA TODAY via Yahoo News· 1 day ago"And here I go already, right off the top 'cause I can’t tell you how nice it's been, the support that I've gotten." York revealed in September 2023 that he was diagnosed with myelodysplastic ...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 12 hours agoThe FDA accepted the company’s biologics license application (BLA) seeking accelerated approval for...
Érik Canuel, director of Bon Cop, Bad Cop and other Quebec hit films, has died at 63
CBC via Yahoo News· 1 day agoHe was 63 years old. Annexe, a Montreal-based communications firm, confirmed Canuel's death on...
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst - Legend...
Benzinga· 2 days agoThe Legend Biotech Analyst: Asthika Goonewardene initiated coverage of Legend Biotech with a Buy...
‘General Hospital’ Star John J. York to Return to Show Following Cancer Battle
Just Jared· 2 days agoJohn J. York is heading back to General Hospital! The 65-year-old soap star, who was diagnosed with...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 2 days agoShanghai based-biotech company CARsgen Therapeutics has announced that its CAR T cell candidate...